Omega Healthcare Investors, Inc. — 2013 Q3 Form 10-Q Summary
Business context and reporting period
Omega is a healthcare real estate investment trust focused primarily on skilled nursing facilities and other long-term-care properties in the United States. The filing covers the three and nine months ended September 30, 2013. At quarter-end, the portfolio comprised 480 healthcare facilities in 34 states, operated by 48 third-party operators, plus mortgage and other investments.
Financial performance and condition
| Metric | Q3 2013 | Q3 2012 | 9M 2013 | 9M 2012 |
|---|---|---|---|---|
| Total operating revenue | $103.3 million | $87.1 million | $307.6 million | $255.4 million |
| Net income available to common stockholders | $38.1 million | $30.1 million | $125.3 million | $86.8 million |
| Diluted EPS | $0.32 | $0.27 | $1.08 | $0.81 |
| Funds from operations available to common stockholders | $70.3 million | $56.7 million | $222.9 million | $160.7 million |
| Operating cash flow | Not separately provided | Not separately provided | $200.1 million | $157.0 million |
| Dividends per common share | $0.47 | $0.42 | $1.38 | $1.25 |
Q3 operating income before other income and expense was $63.3 million, representing an operating margin of approximately 61.3%. Net margin was approximately 36.9%. For the nine-month period, operating income before other income and expense was $192.5 million, or approximately 62.6% of revenue, and net margin was approximately 40.7%.
- Rental income was $93.8 million in Q3 and $280.0 million for the first nine months.
- Depreciation and amortization was $32.2 million in Q3 and $96.4 million for the first nine months.
- Interest expense, including deferred financing cost amortization, was $25.2 million in Q3 and $77.2 million for the first nine months.
- Cash and cash equivalents were $67.8 million at September 30, 2013, compared with $1.7 million at December 31, 2012. Restricted cash was $28.8 million.
- Total assets were $3.0 billion and stockholders’ equity was $1.2 billion at quarter-end.
- Total debt was $1.7 billion, equal to approximately 58.8% of total capitalization. Debt declined from $1.825 billion at December 31, 2012.
- The $500 million revolving credit facility was undrawn, leaving $500 million available; the $200 million term loan was fully outstanding.
- Management reported compliance with applicable affirmative, negative and financial covenants.
Material changes versus prior comparable periods
- Q3 revenue increased $16.2 million, or approximately 18.6%, primarily from 2012 acquisitions, lease amendments and extensions, facility transitions and the capital renovation program.
- Nine-month revenue increased $52.1 million, or approximately 20.4%, primarily from acquired facilities, lease amendments and extensions, renovation-related revenue and higher other investment income.
- Q3 net income increased approximately 26.6%; nine-month net income increased approximately 44.4%. The nine-month comparison benefited from an $11.1 million refinancing gain in 2013 and $5.4 million of refinancing costs in 2012.
- Q3 operating expenses increased $6.0 million, including $3.9 million of additional depreciation and amortization and a $2.3 million provision for uncollectible straight-line rent receivables.
- FFO increased approximately 24.0% in Q3 and 38.6% for the first nine months.
- Operating cash flow increased $43.1 million, or approximately 27.5%, for the first nine months, while investing cash outflow declined to $69.8 million from $228.2 million.
- The company issued approximately 4.4 million shares through its 2013 equity shelf program during the first nine months, generating approximately $136.0 million of gross proceeds. It also issued approximately 1.7 million shares through its dividend reinvestment plan for approximately $47.8 million of net proceeds.
Guidance, outlook, commentary, risks and unusual items
Management stated that available liquidity, including operating cash flow, revolver capacity and expected mortgage payoffs, was adequate to fund operations, debt service, dividends and anticipated investments through the next twelve months. The filing does not provide formal earnings or FFO guidance.
- In August 2013, 11 Arkansas skilled nursing facilities containing 1,084 beds were transitioned to a new operator. The related lease amendment reduced rent and resulted in a $2.3 million provision for uncollectible straight-line receivables. The new lease expires in August 2023 and includes fixed annual escalators.
- Omega committed to a potential $525 million sale/leaseback involving 56 facilities, subject to closing conditions. The proposed 50-year lease would yield 10.7% annually and was expected to be accounted for as a capital lease. Omega funded a $15.0 million deposit.
- In October 2013, Omega completed $33 million of acquisitions involving one assisted living facility and four skilled nursing facilities.
- On October 7, 2013, the company sold 2.875 million shares at $30 per share and received approximately $84.5 million of net proceeds.
- The board declared a quarterly dividend of $0.48 per share payable November 15, 2013, an increase of $0.01 from the prior quarter.
- Key risks include operator financial condition and concentration, Medicare and Medicaid reimbursement reductions, occupancy and regulatory changes, operator bankruptcies and lease rejection, healthcare-sector litigation and compliance, interest-rate and capital-market conditions, competition, and maintaining REIT qualification.
- Genesis and CommuniCare each represented more than 10% of investments and revenue. The largest state concentrations were Florida at 18%, Ohio at 11% and Indiana at 10% of investments.
- Management reported no material changes to previously disclosed market-risk exposures, risk factors or internal controls. Pending litigation was not expected to have a material adverse effect.
Important facts for investors to verify
- Confirm completion, funding, accounting treatment and tenant economics of the proposed $525 million Ark Holding sale/leaseback.
- Monitor the credit quality and payment performance of major operators, particularly Genesis, CommuniCare and the operator involved in the Arkansas transition.
- Assess whether FFO and operating cash flow support the increased dividend and future acquisition activity after debt service and capital investments.
- Review debt maturities, variable-rate exposure, covenant headroom and the continued availability of the $500 million revolving facility.
- Evaluate exposure to Medicare and Medicaid reimbursement changes, sequestration, licensing, quality-of-care enforcement and healthcare regulatory reforms.
- Confirm the effect of equity issuance on per-share results, ownership dilution and dividend coverage.